The most common side effects reported in trials include mild to moderate gastrointestinal issues: nausea, diarrhea, vomiting, and constipation
Then, the package arrives
Timeframe: Week 1720 Dosage: 12.5 mg Cost: $350 Tirzepatide is a next-generation dual GLP-1 and GIP receptor agonist for greater weight loss and metabolic benefits with fewer side effects than Semaglutide
And do you really want your PBM to be doing all your disease management and all that, or do you want to hire the best provider of that service? A deal with Cubans Cost Plus Drugs woudl be the latest effort by Humana to innovate and grow a business in the pharmacy space
Hormone Treatment Centers
"These results support the remarkable potential for people living with type 2 diabetes." In a 40-week Phase 3 randomized, double-blind, placebo-controlled trial for retatrutide, which included 537 participants, the drug showed average A1C reductions of up to 2% and participants lost an average of 36.6 pounds, or roughly 17% weight loss
